Terug
91
Dagbereik
€ 26,49
€ 27,31
52-Weeksbereik
€ 12,91
€ 42,13
Volume
833.782
50D / 200D Gem.
€ 29,58
/
€ 25,90
Vorige Slotkoers
€ 27,75
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -49,2 | 0,3 |
| P/B | 21,5 | 2,9 |
| ROE % | -57,8 | 3,7 |
| Net Margin % | -10,2 | 3,8 |
| Rev Growth 5Y % | 38,9 | 10,0 |
| D/E | 2,9 | 0,2 |
Koersdoel Analisten
Hold
€ 49,00
+82.9%
Forward K/W
73,6
Forward WPA
€ 0,38
WPA Groei (sch.)
+0,0%
Omzet Sch.
700 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 5,07
€ 3,97 – € 6,32
|
1,5 B | 2 |
| FY2029 |
€ 4,07
€ 3,19 – € 5,08
|
1,3 B | 4 |
| FY2028 |
€ 3,41
€ 2,02 – € 5,75
|
1,1 B | 6 |
Belangrijkste Punten
Revenue grew 38,90% annually over 5 years — strong growth
Debt/Equity of 2,86 — high leverage
Generating 37,78M in free cash flow
PEG of 0,79 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 71,55%
Capital efficient — spends only 0,00% of revenue on capex
Groei
Revenue Growth (5Y)
38,90%
Revenue (1Y)110,45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-57,80%
ROIC-10,62%
Net Margin-10,24%
Op. Margin-12,80%
Veiligheid
Debt / Equity
2,86
Current Ratio2,74
Interest Coverage-5,85
Waardering
P/E Ratio
-49,17
P/B Ratio21,52
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 110,45% | Revenue Growth (3Y) | 83,81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38,90% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 490,73M | Net Income (TTM) | -50,26M |
| ROE | -57,80% | ROA | -8,30% |
| Gross Margin | 85,51% | Operating Margin | -12,80% |
| Net Margin | -10,24% | Free Cash Flow (TTM) | 37,78M |
| ROIC | -10,62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,86 | Current Ratio | 2,74 |
| Interest Coverage | -5,85 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -49,17 | P/B Ratio | 21,52 |
| P/S Ratio | 5,04 | PEG Ratio | 0,79 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,47B | Enterprise Value | 2,71B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 490,73M | 233,18M | 145,24M | 109,46M | 131,84M |
| Net Income | -50,26M | -321,55M | -111,40M | -278,48M | -180,09M |
| EPS (Diluted) | -0,56 | -4,08 | -1,50 | -4,37 | -3,01 |
| Gross Profit | 419,65M | 225,43M | 133,79M | 105,04M | 128,02M |
| Operating Income | -62,82M | -323,83M | -388,14M | -319,81M | -199,43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 605,19M | 594,13M | 788,91M | 672,59M | 776,63M |
| Total Liabilities | 490,36M | 535,05M | 588,10M | 629,73M | 474,52M |
| Shareholders' Equity | 114,83M | 59,08M | 200,81M | 42,85M | 302,11M |
| Total Debt | 328,73M | 401,58M | 404,78M | 407,49M | 261,99M |
| Cash & Equivalents | 93,04M | 58,54M | 58,18M | 61,69M | 165,75M |
| Current Assets | 437,57M | 416,70M | 616,78M | 486,44M | 582,83M |
| Current Liabilities | 159,90M | 200,75M | 177,91M | 142,16M | 124,09M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#1 of 146
Recente Activiteit
Ingestapt
Full Throttle
Mar 24, 2026